Literature DB >> 25618623

FDA grants accelerated approval for ibrutinib for CLL.

Surabhi Dangi-Garimella.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25618623

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN： 1088-0224            Impact factor:   2.229


× No keyword cloud information.
  2 in total

1.  Bruton Tyrosine Kinase-Dependent Immune Cell Cross-talk Drives Pancreas Cancer.

Authors:  Andrew J Gunderson; Megan M Kaneda; Takahiro Tsujikawa; Abraham V Nguyen; Nesrine I Affara; Brian Ruffell; Sara Gorjestani; Shannon M Liudahl; Morgan Truitt; Peter Olson; Grace Kim; Douglas Hanahan; Margaret A Tempero; Brett Sheppard; Bryan Irving; Betty Y Chang; Judith A Varner; Lisa M Coussens
Journal:  Cancer Discov       Date:  2015-12-29       Impact factor: 39.397

2.  Tuned out.

Authors:  Fleur M Ferguson
Journal:  Nat Chem Biol       Date:  2022-09       Impact factor: 16.174
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.